ATE132750T1 - Behandlung von intraokularem druck mit einer synergischen kombination - Google Patents

Behandlung von intraokularem druck mit einer synergischen kombination

Info

Publication number
ATE132750T1
ATE132750T1 AT91304576T AT91304576T ATE132750T1 AT E132750 T1 ATE132750 T1 AT E132750T1 AT 91304576 T AT91304576 T AT 91304576T AT 91304576 T AT91304576 T AT 91304576T AT E132750 T1 ATE132750 T1 AT E132750T1
Authority
AT
Austria
Prior art keywords
intraocular pressure
treating intraocular
synergic combination
combination
synergic
Prior art date
Application number
AT91304576T
Other languages
English (en)
Inventor
Ryuji Ueno
Original Assignee
R Tech Ueno Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by R Tech Ueno Ltd filed Critical R Tech Ueno Ltd
Application granted granted Critical
Publication of ATE132750T1 publication Critical patent/ATE132750T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
AT91304576T 1990-05-22 1991-05-21 Behandlung von intraokularem druck mit einer synergischen kombination ATE132750T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP13291090 1990-05-22

Publications (1)

Publication Number Publication Date
ATE132750T1 true ATE132750T1 (de) 1996-01-15

Family

ID=15092386

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91304576T ATE132750T1 (de) 1990-05-22 1991-05-21 Behandlung von intraokularem druck mit einer synergischen kombination

Country Status (10)

Country Link
US (1) US5166175A (de)
EP (1) EP0458590B1 (de)
JP (1) JP2511585B2 (de)
KR (1) KR960010435B1 (de)
AT (1) ATE132750T1 (de)
CA (1) CA2042937C (de)
DE (1) DE69116224T2 (de)
DK (1) DK0458590T3 (de)
ES (1) ES2084771T3 (de)
GR (1) GR3018651T3 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6420422B1 (en) 1987-09-18 2002-07-16 Sucampo Pharmaceuticals, Inc. Ocular hypotensive agents
PT561073E (pt) * 1992-03-19 2002-04-29 R Tech Ueno Ltd Tratamento da hipertensao ocular com beta-bloqueadores e derivados de acido prostanoico
EP0668076B1 (de) * 1992-08-26 2002-09-04 Sucampo AG Stabilisierung von Prostansäurederivaten
JPH06107547A (ja) * 1992-10-01 1994-04-19 Aarutetsuku Ueno:Kk 眼科用組成物
US20020133009A1 (en) * 2001-03-13 2002-09-19 Lambrou George N. Method for opening potassium channels
TWI298257B (en) 2001-05-31 2008-07-01 Allergan Inc Hypotensive lipid and timolol compositions and methods of using same
WO2003082257A2 (en) * 2002-03-28 2003-10-09 Sucampo Ag Method for treating ocular hypertension and glaucoma
TWI348386B (en) * 2003-08-12 2011-09-11 R Tech Ueno Ltd Composition and method for promoting hair growth
US9061034B2 (en) 2010-07-29 2015-06-23 Allergan, Inc. Preservative free bimatoprost and timolol solutions
HUE059325T2 (hu) 2010-07-29 2022-11-28 Allergan Inc Tartósítószer-mentes bimatoprost és timolol oldatok

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4599353A (en) * 1982-05-03 1986-07-08 The Trustees Of Columbia University In The City Of New York Use of eicosanoids and their derivatives for treatment of ocular hypertension and glaucoma
EP0242580B1 (de) * 1986-03-13 1993-04-28 The Trustees Of Columbia University In The City Of New York Verwendung von A-, B- und C-Prostaglandinen und deren Derivaten zur Behandlung von Augen-Hypertension und Glaukom
US4824857A (en) * 1986-05-16 1989-04-25 Yasumasa Goh Use of prostaglandin D2 -active substances
ATE76750T1 (de) * 1987-04-03 1992-06-15 Univ Columbia Anwendung eines prostaglandins in mischung mit einem adrenergischen blocker zur verminderung des augen-innendruckes.
US4952581A (en) * 1987-04-03 1990-08-28 The Trustees Of Columbia University In The City Of New York Use of a prostaglandin in combination with an adrenergic blocking agent for reduction of intraocular pressure
GB2209939B (en) * 1987-09-18 1992-01-02 R Tech Ueno Ltd The use of 13,14-dihydro-15-keto-prostaglandins as ocular hypotensive agents
EP0366279B1 (de) * 1988-10-01 1994-09-21 R-Tech Ueno Ltd. Okulare hypotensive Mittel

Also Published As

Publication number Publication date
JPH04253911A (ja) 1992-09-09
US5166175A (en) 1992-11-24
KR910019621A (ko) 1991-12-19
JP2511585B2 (ja) 1996-06-26
CA2042937A1 (en) 1991-11-23
EP0458590A1 (de) 1991-11-27
KR960010435B1 (ko) 1996-08-01
DE69116224D1 (de) 1996-02-22
GR3018651T3 (en) 1996-04-30
ES2084771T3 (es) 1996-05-16
DE69116224T2 (de) 1996-05-23
CA2042937C (en) 2002-04-30
DK0458590T3 (da) 1996-02-05
EP0458590B1 (de) 1996-01-10

Similar Documents

Publication Publication Date Title
ATE169219T1 (de) Behandlung von katarakt mit 15-keto- prostaglandinderivaten
ATE107515T1 (de) Zusammensetzung zur behandlung von entzündung.
DE69719931D1 (de) Verwendung von Acetylcystein zur Herstellung eines Arzneimittels zur Behandlung von chronischen Geschwüren
ATE133663T1 (de) Antiglancoma-zusammensetzungen enthaltend 3- arylcarbonyl-1-aminoalkyl-1h-indol
DE69116224D1 (de) Behandlung von intraokularem Druck mit einer synergischen Kombination
DE69106777D1 (de) Behandlung von intraokularem Druck mit einer ophthalmischen synergistischen Kombination.
ATE174221T1 (de) Behandlung von pankreaskrankheit mit 15-keto- prostaglandin e-derivaten
ATE114470T1 (de) Behandlung von intraocularem druck mit einer synergistischen kombination zur ophthalmischen verwendung.
EP0463126A4 (en) Methods of enhancing wound healing and tissue repair
DE69301387D1 (de) Behandlung des Glaukoms mit synergistischer Kombination
DE69032000D1 (de) Behandlung kardialer Dysfunktion mit 15-Ketoprostaglandinderivaten
ATE91419T1 (de) Synergistische kombination zur ophthalmischen verwendung.
DE69023459D1 (de) Behandlung von pulmonarer Disfunktion mit 15-Keto-prostaglandin-Derivaten.
ATE137407T1 (de) Behandlung von intraocularem druck mit einer synergistischen kombination
ATE178336T1 (de) Verwendung einer therapeutischen zusammensetzung zur behandlung von bronchitis
DE69124415D1 (de) Verwendung von 15-Dehydroxy-16-Oxoprostaglandin bei der Behandlung von allergischen Erkrankungen
ATE72115T1 (de) Anwendung von 1,6-dimethyl-4-oxo-1,6,7,8,9a-
ES8500951A1 (es) Un procedimiento para preparar 6-metil-tio-espiro-ckroman-4,4' imidazolin-2',5'-diona.
DE69001988D1 (de) Behandlung des schocks mit cyclodextrin und dessen derivaten.
DE69215191D1 (de) Verwendung von thiol-5-(2-diethyl-aminoethyl)-ester-Verbindungen zur Herstellung eines Arzneimittels zur Behandlung der neuromuskuläre Inkontinenz

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee